MedTrace Logo

Reverse-Loop Upper Arm Arteriovenous Graft

NCT00708825 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2008-07-02

No results posted yet for this study

Summary

Background: A conventional configured prosthetic arteriovenous graft (AVG) usually wastes most upper arm vessels that a reverse-loop design may conserve. This study examined the feasibility of the AVG construction and its outcome.

Methods: Retrospective review of clinical outcomes of reverse-loop upper arm AVG patients. Measures included hemodialysis function, duplex scan, procedural complications, and follow-up interventions

Conditions

  • Blood Vessel Prosthesis

Sponsors & Collaborators

  • Min-Sheng General Hospital

    collaborator OTHER

  • Far Eastern Memorial Hospital

    lead OTHER

Principal Investigators

  • Chih-Yang Chan, MD, PhD · Far Eastern Memorial Hospital

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00708825 on ClinicalTrials.gov